Provider - Focused Strategies: Prescriber - Prescribing Restrictions

Sunil Agarwal A, Bryan JD, Hu HM, et al. Association of state opioid duration limits with postoperative opioid prescribing. JAMA Netw Open. 2019 2;2(12):e1918361.  Article

Ballotpedia. Opioid prescription limits and policies by state.  Article

Bulloch M. Opioid prescribing limits across the states. Pharmacy Times. 5 Feb 2019.  Article

Chua KP, Brummett CM, Waljee JF. Opioid prescribing limits for acute pain: potential problems with design and implementation. JAMA. 2019;321(7):643-4.  Article

Davis CS, Lieberman AJ, Hernandez-Delgado H, Suba C. Laws limiting the prescribing or dispensing of opioids for acute pain in the United States: a national systematic legal review. Drug Alcohol Depend. 2019;194:166-72.  Abstract

National Conference of State Legislatures. Prescribing policies: states confront opioid overdose epidemic. Link

Reid DBC, Patel SA, Shah KN, et al. Opioid-limiting legislation associated with decreased 30-day opioid utilization following anterior cervical decompression and fusion. Spine J. 2020;20(1):69-77.  Abstract

Rao T, Kiptanui Z, Dowell P, et al. Association of formulary exclusions and restrictions for opioid alternatives with opioid prescribing among medicare beneficiaries. JAMA Netw Open. 2020;3(3):e200274.  Article

McGerald G, Dvorkin R, Levy D, et al. Prescriptions for schedule II opioids and benzodiazepines increase after the introduction of computer-generated prescriptions. Acad Emerg Med. 2009;16(6):508-12.  Article

Ong MK, Xu H, Zhang L, et al. Effect of Medicare Part D benzodiazepine exclusion on psychotropic use in benzodiazepine users. J Am Geriatr Soc. 2012;60:1292-7.  Article

Ong MK, Zhang L, Xu H, et al. Medicare Part D benzodiazepine exclusion and use of psychotropic medication by patients with new anxiety disorders. Psychiatr Serv.. 2012;63:637-42. Article

Ross-Degnan D, Simoni-Wastila L. Brown JS, et al. A controlled study of the effects of state surveillance on indicators of problematic and non-problematic benzodiazepine use in a Medicaid population. Int J Psychiatry Med. 2004;34(2):103-23.  Link

Simoni-Wastilla L, Ross-Degnan D, Mah C, et al. A retrospective data analysis of the impact of the New York triplicate prescription program on benzodiazepine use in medicaid patients with chronic psychiatric and neurologic disorders. Clin Ther. 2004;26(2):322-36.  Link